BBTX BAMBUSA THERAPEUTICS INC
FollowCommon Stock, par value $0.00001 per share (common), issuer CIK 2044950
No 13F filer reports this security in the loaded quarters.
13D and 13G filers
Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.
- RA CAPITAL MANAGEMENT, L.P.(group RA CAPITAL MANAGEMENT, L.P.)
7,429,758 shares, 14.6% in a 13D as of 2026-10-30,0001346824-26-000253
Accepted , ingested - ATHOS KG (group ATHOS KG)
4,699,188 shares, 9.2% in a 13G as of 2026-10-29,0002085929-26-000014
Accepted , ingested
Insider trades
No Form 4 transaction on this security in the data.
Events
RA CAPITAL MANAGEMENT, L.P. and 3 other reporting persons reported 7,429,758 BBTX shares, 14.6% of the class, as of 2026-10-30, in a 13D filed 2026-11-06. 0001346824-26-000253
Accepted , ingestedATHOS KG and 3 other reporting persons reported 4,699,188 BBTX shares, 9.2% of the class, as of 2026-10-29, in a 13G filed 2026-11-05. 0002085929-26-000014
Accepted , ingested